As healthcare continues to move toward outcome based reimbursement, the innovation in Telemedicine is surging again. The monitoring of cardiac symptoms, chronic diseases and overall post discharge wellness is requiring more modern and non-invasive solutions. Blind-i is proud to sign an agreement with the only FDA approved leadless ECG manufacturer. Bind-i will assist in launching this revolutionary Class II medical device. Compared to a traditional Holter monitor this new technology makes it easier and more comfortable for patience requiring wearing a device to monitor abnormal heart rhythms. Blind-i continues to work with innovative healthcare technology leaders demonstrating the quality and confidence in the capabilities of the Blind-i team.